ArticleAfrican health sciences2019
Determinants of prostate specific antigen screening test uptake in an urban community in North-Central Nigeria.
Article in African health sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 17 citations in OpenAlex.
- Article
- Individual and Socioeconomic Affecting Factors for Prostate Cancer Screening Behavior.The world journal of men's health · 2025Review
- Facilitators of, and barriers to, prostate cancer screening uptake: A descriptive phenomenological study of adult men in Namibia.BMC urology · 2025Article
- Barriers and sources of information in prostate cancer screening at a South African hospital.Journal of public health in Africa · 2025Article
- Awareness, knowledge, and factors that influenced the uptake of screening tests for prostate cancer among men aged 40 and older in Ido-Ekiti, Ekiti State, Nigeria.Journal of public health in Africa · 2023Article
- A Bone Scan Is Valuable for Primary Staging of Newly Diagnosed Prostate Cancer in a Low-Resource Setting (Nigeria).Nuclear medicine and molecular imaging · 2022Article
- Comparison of health access, lifestyle, prostate cancer knowledge and screening among black men residing in West Africa and the USA.Ecancermedicalscience · 2021Article
- Prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran.BMC geriatrics · 2020Article
- Infections, NCDS, and the scourge of cyclones and Ebola in sub-Saharan Africa.African health sciences · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the increasing incidence of Prostate cancer, there has not been any focused screening policy or strategy in sub-Saharan Africa including Nigeria.
objectivesTo assess the level of awareness and uptake of PSA screening test and their determinants in a Nigerian community.
methodsA cross-sectional population survey of men with no prior history of prostate cancer was carried out. Logistic regression analysis was used to determine the effect of identified variables in predicting awareness and uptake of prostate cancer screening.
resultsMean age was 51.5±9.8 years; a few men (31, 16.9%) had ever heard of the screening test and most got the information from health centers. A low proportion (8, 4.4%) had taken the screening test. Men with incomes above poverty line (OR = 11.7 2.8-50.1, p = .001) or those with health insurance (OR = 2.7 1.2-6.5, p = .023) were significantly more likely to be aware of the test. Only the men with higher incomes (OR = 25.6 5.8-114.2, p = .0001) were significantly more likely to have taken the test.
conclusionHigher incomes and health insurance status impact screening awareness but only income status determines if men subsequently proceed to take the PSA screening test.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.